| Title |
Early Release - Rhabdomyolysis as Potential Late Complication Associated with COVID-19 - Volume 26, Number 7—July 2020 - Emerging Infectious Diseases journal - CDC
|
|---|---|
| Published in |
Emerging Infectious Diseases, June 2020
|
| DOI | 10.3201/eid2607.200445 |
| Pubmed ID | |
| Authors |
Min Jin, Qiaoxia Tong |
| Abstract |
We describe a patient in Wuhan, China, with severe acute respiratory syndrome coronavirus 2 infection who had progressive pulmonary lesions and rhabdomyolysis with manifestations of lower limb pain and fatigue. Rapid clinical recognition of rhabdomyolysis symptoms in patients with severe acute respiratory syndrome coronavirus 2 infection can be lifesaving. |
X Demographics
The data shown below were collected from the profiles of 77 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 14 | 18% |
| Canada | 3 | 4% |
| United Kingdom | 2 | 3% |
| Spain | 2 | 3% |
| Switzerland | 1 | 1% |
| Georgia | 1 | 1% |
| Belgium | 1 | 1% |
| Mauritius | 1 | 1% |
| Netherlands | 1 | 1% |
| Other | 5 | 6% |
| Unknown | 46 | 60% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 63 | 82% |
| Scientists | 8 | 10% |
| Practitioners (doctors, other healthcare professionals) | 4 | 5% |
| Science communicators (journalists, bloggers, editors) | 2 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 449 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 449 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 63 | 14% |
| Student > Ph. D. Student | 37 | 8% |
| Student > Postgraduate | 34 | 8% |
| Student > Bachelor | 33 | 7% |
| Other | 31 | 7% |
| Other | 104 | 23% |
| Unknown | 147 | 33% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 113 | 25% |
| Biochemistry, Genetics and Molecular Biology | 23 | 5% |
| Nursing and Health Professions | 21 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 16 | 4% |
| Agricultural and Biological Sciences | 12 | 3% |
| Other | 92 | 20% |
| Unknown | 172 | 38% |
Attention Score in Context
This research output has an Altmetric Attention Score of 58. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 02 March 2023.
All research outputs
#753,752
of 25,782,917 outputs
Outputs from Emerging Infectious Diseases
#903
of 9,786 outputs
Outputs of similar age
#22,808
of 434,964 outputs
Outputs of similar age from Emerging Infectious Diseases
#77
of 226 outputs
Altmetric has tracked 25,782,917 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 9,786 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 46.1. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 434,964 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 226 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 65% of its contemporaries.